START Clinic for Mood and Anxiety Disorders Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Toronto Canada

Organization Overview

First Clinical Trial
2008
NCT00485888
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dr. Martin A. Katzman | START Clinic for Mood and Anxiety Disorders | START Clinic for the Mood and Anxiety Disorders

Active Ingredients

Drugs in Phase 4 Trials (2)

cariprazine (vraylar) (1 trial)

desvenlafaxine (pristiq) (1 trial)

Drugs in Phase 3 Trials (1)

quetiapine (seroquel) (1 trial)

Drugs in Phase 2 Trials (2)

escitalopram (lexapro) (1 trial)

icosapent ethyl (vascepa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Phobia, Social (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5